BIOLOGICS CONSULTING GROUP, INC.

Biologics Consulting Group, Inc. specializes in providing scientific and technical consulting services focused on biologics and life sciences expertise, primarily supporting federal health and regulatory missions. Their core capabilities center on subject matter expert advisory services for biologics development, regulatory strategy, and scientific evaluation—particularly in areas such as vaccine platforms, monoclonal antibodies, cell and gene therapies, and biosimilar pathways. The firm delivers high-level technical guidance to inform policy, review clinical and preclinical data, and assess product safety and efficacy within complex regulatory frameworks. Their differentiated strength lies in deep domain knowledge of biologics lifecycle management, enabling precise, evidence-based consultations that align with FDA and CDC standards. This niche focus distinguishes them as a trusted advisor for agencies requiring scientifically rigorous, non-commercial oversight in advanced therapeutic development. The company’s primary agency engagement is with the Department of Health and Human Services, where they provide specialized biologics SME support to components such as the FDA, CDC, or NIH. Their work supports mission-critical functions including product evaluation, scientific review panels, and regulatory decision-making processes, indicating a consistent, mission-aligned partnership built on technical credibility rather than volume. Their primary NAICS classification—541690, Other Scientific and Technical Consulting Services—reflects a focused practice in applied life sciences consultation, distinguishing them from generalist IT or management consultants. They operate at the intersection of regulatory science and biopharmaceutical innovation, positioning themselves as a precision consultant for complex biological product development and evaluation. Biologics Consulting Group, Inc. is a small business structured as a 2L entity, headquartered in Alexandria, Virginia. While currently holding no formal government certifications, their geographic proximity to federal health agencies and specialized technical workforce enable targeted, high-impact engagement within the federal biologics ecosystem.